VIVS Stock Analysis: Buy, Sell, or Hold?

VIVS - VivoSim Labs, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.29
0.01 (2.10%) ▲
5d: -8.18%
30d: -30.29%
90d: -78.53%
HOLD
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026 0d

Get Alerted When VIVS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: VIVS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: VIVS is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.29 to $0.46.

Technical Outlook: Technically, VIVS is in a strong downtrend. Immediate support is located at $0.26, while resistance sits at $0.37.

Market Sentiment: VIVS scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.29 - $0.46
Company Quality Score 54/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 94.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (68/100)
  • BULLISH: High volume confirmation
  • CAUTION: Bottoming setup, but lagging the sector by 25% over 20 days — wait for relative strength
  • CAUTION: 5-day price weakness (-8.2%) - monitor closely

Trading Range Analysis

30-Day Trading Range $0.29 - $0.46
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.26
Resistance Level $0.37
Current Trend Strong Downtrend
Technical data as of Aug 24, 2026

Fundamental Context

Revenue Growth (YoY) -51.4%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 25, 2026 9:17 AM ET
Data refreshes hourly during market hours. Next update: 10:17 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for VIVS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RARE
Ultragenyx
STRONG BUY
20 analysts
$55 62 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$88 37 SELL
RCKT
Rocket Pharmaceuticals I…
STRONG BUY
18 analysts
$9 47 HOLD
EYPT
EyePoint, Inc
STRONG BUY
13 analysts
$27 49 HOLD

More Analysis for VIVS

VIVS Technical Chart VIVS Price Prediction VIVS Earnings Date VIVS Investment Advisor VIVS Fair Price Analyzer VIVS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals